191 related articles for article (PubMed ID: 35327325)
1. Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET.
Gilardi L; Airò Farulla LS; Demirci E; Clerici I; Omodeo Salè E; Ceci F
Biomedicines; 2022 Feb; 10(3):. PubMed ID: 35327325
[TBL] [Abstract][Full Text] [Related]
2. FAPI PET/CT Imaging-An Updated Review.
Chandekar KR; Prashanth A; Vinjamuri S; Kumar R
Diagnostics (Basel); 2023 Jun; 13(12):. PubMed ID: 37370912
[TBL] [Abstract][Full Text] [Related]
3. The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies.
Dong Y; Zhou H; Alhaskawi A; Wang Z; Lai J; Yao C; Liu Z; Hasan Abdullah Ezzi S; Goutham Kota V; Hasan Abdulla Hasan Abdulla M; Lu H
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831535
[TBL] [Abstract][Full Text] [Related]
4.
Kratochwil C; Flechsig P; Lindner T; Abderrahim L; Altmann A; Mier W; Adeberg S; Rathke H; Röhrich M; Winter H; Plinkert PK; Marme F; Lang M; Kauczor HU; Jäger D; Debus J; Haberkorn U; Giesel FL
J Nucl Med; 2019 Jun; 60(6):801-805. PubMed ID: 30954939
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers.
Syed M; Flechsig P; Liermann J; Windisch P; Staudinger F; Akbaba S; Koerber SA; Freudlsperger C; Plinkert PK; Debus J; Giesel F; Haberkorn U; Adeberg S
Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2836-2845. PubMed ID: 32447444
[TBL] [Abstract][Full Text] [Related]
6.
Giesel FL; Kratochwil C; Lindner T; Marschalek MM; Loktev A; Lehnert W; Debus J; Jäger D; Flechsig P; Altmann A; Mier W; Haberkorn U
J Nucl Med; 2019 Mar; 60(3):386-392. PubMed ID: 30072500
[TBL] [Abstract][Full Text] [Related]
7. Design and Development of
Lindner T; Altmann A; Krämer S; Kleist C; Loktev A; Kratochwil C; Giesel F; Mier W; Marme F; Debus J; Haberkorn U
J Nucl Med; 2020 Oct; 61(10):1507-1513. PubMed ID: 32169911
[TBL] [Abstract][Full Text] [Related]
8. Improved cancer detection in Waldeyer's tonsillar ring by
Serfling S; Zhi Y; Schirbel A; Lindner T; Meyer T; Gerhard-Hartmann E; Lapa C; Hagen R; Hackenberg S; Buck AK; Scherzad A
Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1178-1187. PubMed ID: 33057927
[TBL] [Abstract][Full Text] [Related]
9. Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention.
Loktev A; Lindner T; Burger EM; Altmann A; Giesel F; Kratochwil C; Debus J; Marmé F; Jäger D; Mier W; Haberkorn U
J Nucl Med; 2019 Oct; 60(10):1421-1429. PubMed ID: 30850501
[TBL] [Abstract][Full Text] [Related]
10. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O
J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144
[TBL] [Abstract][Full Text] [Related]
11. State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis.
Sollini M; Kirienko M; Gelardi F; Fiz F; Gozzi N; Chiti A
Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4396-4414. PubMed ID: 34173007
[TBL] [Abstract][Full Text] [Related]
12. Comparison of
Pang Y; Zhao L; Luo Z; Hao B; Wu H; Lin Q; Sun L; Chen H
Radiology; 2021 Feb; 298(2):393-402. PubMed ID: 33258746
[TBL] [Abstract][Full Text] [Related]
13. FAP and FAPI-PET/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis?
Dendl K; Koerber SA; Kratochwil C; Cardinale J; Finck R; Dabir M; Novruzov E; Watabe T; Kramer V; Choyke PL; Haberkorn U; Giesel FL
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638433
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation and pilot clinical study of [
Hu K; Li J; Wang L; Huang Y; Li L; Ye S; Han Y; Huang S; Wu H; Su J; Tang G
Acta Pharm Sin B; 2022 Feb; 12(2):867-875. PubMed ID: 35256951
[TBL] [Abstract][Full Text] [Related]
15. Preparation and Bioevaluation of
Ruan Q; Feng J; Jiang Y; Zhang X; Duan X; Wang Q; Yin G; Xiao D; Zhang J
Mol Pharm; 2022 Jan; 19(1):160-171. PubMed ID: 34904839
[TBL] [Abstract][Full Text] [Related]
16. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [
Guo W; Pang Y; Yao L; Zhao L; Fan C; Ke J; Guo P; Hao B; Fu H; Xie C; Lin Q; Wu H; Sun L; Chen H
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1604-1617. PubMed ID: 33179149
[TBL] [Abstract][Full Text] [Related]
17. Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a
Varasteh Z; Mohanta S; Robu S; Braeuer M; Li Y; Omidvari N; Topping G; Sun T; Nekolla SG; Richter A; Weber C; Habenicht A; Haberkorn UA; Weber WA
J Nucl Med; 2019 Dec; 60(12):1743-1749. PubMed ID: 31405922
[TBL] [Abstract][Full Text] [Related]
18. PET/CT with Fibroblast Activation Protein Inhibitors in Breast Cancer: Diagnostic and Theranostic Application-A Literature Review.
Taralli S; Lorusso M; Perrone E; Perotti G; Zagaria L; Calcagni ML
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765866
[TBL] [Abstract][Full Text] [Related]
19.
Lindner T; Altmann A; Giesel F; Kratochwil C; Kleist C; Krämer S; Mier W; Cardinale J; Kauczor HU; Jäger D; Debus J; Haberkorn U
EJNMMI Radiopharm Chem; 2021 Aug; 6(1):26. PubMed ID: 34417894
[TBL] [Abstract][Full Text] [Related]
20. Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [
Treglia G; Muoio B; Roustaei H; Kiamanesh Z; Aryana K; Sadeghi R
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
